Please upgrade your browser to make full use of twiends.   chrome   firefox   ie   safari  
Want your own social home page like this one? Click here.
$CYTK..$9.20 up 4%
$IBB and $XBI both up 1.5% today. Let's see if it holds here.
$POZN..$8.40 watching here. Seems to have locked into this $8.35-$8.55 price range b4 April 25th PDUFA.
$CMXI..$.56 back on my radar. I like the risk/reward.
CombinatoRx fails, changes name to Zalicus ($ZLCS) , fails again and ends up a shell for Epirus reverse merger. Beautiful business biotech
Retweeted by SheffStation
$ECYT..$17.33 down 7%
IMO, fake early morning market action. Be patient here.
Retweeted by SheffStation
"To believe in your choice you don’t need to prove that other people’s choices are wrong." — Paulo Coelho
"There is only one time that is important -Now! It is the most important time because it is the only time when we have any power." ~ Tolstoy
"The brick walls aren't there to keep us out, the brick walls are there to give us a chance to show how badly we want something." -R Pausch
"The real measure of our wealth is how much we'd be worth if we lost all our money." -Jowett
$IBB - Imho the safest play would (good post)
Every Retweet this gets = a Thank You to Jackie. #Jackie42
Retweeted by SheffStation
Always research a financial professional’s background before hiring them. Learn more at
Retweeted by SheffStation
51,500+ stockbrokers failed basic exam needed to sell securities at least once, WSJ analysis shows @jeaneaglesham
Retweeted by SheffStation
"No one has ever made himself great by showing how small someone else is." -Irvin Himmel
$CNDO corp presentation via 8-k..April 2014
$GALE filing to sell 6m shares at $2.06 for 12.36m.
SportCenter Featured: "Boston Strong" Great story days before the 2014 Boston Marathon on 4/21. #BostonStrong
$BMRN..BioMarin says FDA extends Kuvan market exclusivity by six months.
#IBS treatments aren’t one-size-fits-all. #FDA is working to bring more options to patients:
Retweeted by SheffStation
$BIND Therapeutics barasertib data positive, says JMP Securities.
$SYN..Synthetic Biologics Appts Mark Pimentel, M.D., Chair of New Irritable Bowel Syndrome Clinical Advisory Board.